Ligand Pharmaceuticals traded at $84.06 this Friday May 20th, increasing $1.32 or 1.60 percent since the previous trading session. Looking back, over the last four weeks, Ligand Pharmaceuticals gained 18.21 percent. Over the last 12 months, its price fell by 31.96 percent. Looking ahead, we forecast Ligand Pharmaceuticals to be priced at 81.98 by the end of this quarter and at 76.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
84.06
Daily Change
1.60%
Yearly
-31.96%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acorda Therapeutics 0.54 -0.01 -2.63% -86.92%
Agenus 1.61 0.07 4.55% -61.48%
Amgen 247.47 2.70 1.10% -1.41%
Anika Therapeutics 21.42 -0.47 -2.15% -51.38%
Arrowhead Research 35.91 0.76 2.16% -51.95%
Baxter International 73.23 0.58 0.79% -11.83%
Bristol-Myers Squibb 76.20 0.24 0.32% 13.65%
Clovis Oncology 0.73 0.02 2.52% -86.15%
Endo International 0.46 -0.11 -19.56% -91.69%
Enanta Pharmaceuticals 44.23 0.22 0.50% -9.10%
Gilead Sciences 63.89 0.62 0.98% -7.07%
GlaxoSmithKline 1,757.20 25.60 1.48% 29.68%
Glaxosmithkline 44.32 0.76 1.74% 13.55%
Heron Therapeutics 3.70 0.13 3.68% -74.03%
Harsco 7.90 0.08 1.02% -64.53%
Immunogen 3.67 0.14 3.82% -42.82%
Insmed 19.91 0.34 1.74% -24.21%
Ionis Pharmaceuticals 39.15 0.02 0.05% 7.08%
Karyopharm Therapeutics 5.86 0.21 3.72% -38.51%
Lannett 0.53 0.003 0.65% -88.72%
Ligand Pharmaceuticals 84.06 1.32 1.60% -31.96%
Eli Lilly 299.17 12.90 4.51% 49.67%
MacroGenics 4.03 0.13 3.21% -86.65%
Merck & Co 93.58 1.49 1.62% 18.19%
Pacira 63.72 0.68 1.08% -3.91%
Pfizer 52.49 1.84 3.63% 31.39%
Rigel Pharmaceuticals 2.15 0.03 1.18% -41.71%
Sangamo BioSciences 4.10 0.10 2.50% -62.52%
Spectrum Pharmaceuticals 0.71 -0.03 -3.89% -78.81%
Teva Pharmaceutical Industries 8.48 0.17 2.05% -21.26%
Veracyte 17.76 0.29 1.66% -52.17%
Intrexon 1.26 0.01 0.40% -81.41%

Indexes Price Day Year
USND 11355 -33.88 -0.30% -15.71%
US400 2385 -6.53 -0.27% -11.34%

Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.